Types and Treatment of Perianal Fistulas
The optimal management of perianal fistulas requires classification into simple or complex types, with first-line treatment being a combination of surgical seton placement and medical therapy with anti-TNF agents (preferably infliximab) for most cases. 1
Classification of Perianal Fistulas
Perianal fistulas are classified as simple or complex according to the American Gastroenterological Association 1:
- Simple fistulas: Low intersphincteric or trans-sphincteric fistulas with a single external opening
- Complex fistulas: High intersphincteric, high trans-sphincteric, extrasphincteric, or suprasphincteric fistulas, often with multiple external openings
Accurate diagnosis requires imaging with MRI or endoanal ultrasound to define fistula anatomy, and endoscopy to assess for active rectal disease 1
Treatment Approach
Initial Management
Examination under anesthesia should include assessment of the rectal mucosa, as the presence of proctitis is associated with lower rates of fistula healing 2
The standard of care involves initial seton placement followed by medical therapy, particularly anti-TNF agents 1
Medical Treatment Options
For simple perianal fistulas: 1
- First-line: Metronidazole and/or ciprofloxacin
- Second-line: Azathioprine or mercaptopurine
- Third-line: Infliximab
For complex perianal fistulas: 1
- First-line: Anti-TNF therapy (preferably infliximab) combined with immunomodulators
- Adjunctive therapy: Antibiotics such as metronidazole and ciprofloxacin
Infliximab has demonstrated superior efficacy for fistulizing Crohn's disease: 3
- 68% of patients receiving 5 mg/kg infliximab showed fistula response (≥50% reduction in draining fistulas)
- Complete closure of all fistulas was achieved in 52% of infliximab-treated patients compared to 13% with placebo
Surgical Treatment Options
For simple fistulas: Fistulotomy has the highest success rate 1
For complex fistulas: Non-cutting setons, advancement flaps, and ligation of intersphincteric fistula tract (LIFT) are considered based on fistula characteristics 1
Commonly performed procedures for perianal Crohn's disease include: 2
- Removal of draining seton (70.7%)
- Fistulotomy (57.1%)
- Advancement flap (38.9%)
- Fistula plug (36.4%)
- LIFT procedure (31.8%)
Video-assisted anal fistula treatment (VAAFT) combined with advancement flap has shown 82% success rate at 9 months in complex fistulizing Crohn's disease 2
Combined Approach
A combined medical and surgical approach yields better outcomes than either approach alone 4:
- Complete remission rates: 52% with combination therapy vs. 43% with single therapy
- Non-response rates: 23% with combination therapy vs. 34% with single therapy
Careful preparation of the fistula track with curettage to destroy epithelial tissue and ligation of the internal opening should be considered as standard treatment 2
Management of Refractory Cases
For refractory cases, options include: 1
- Hyperbaric oxygen therapy
- Fecal diversion
- Proctectomy (last resort for severe disease with irreversible perineal destruction)
Expanded allogeneic adipose-derived stem cells have shown promise for treatment-refractory complex perianal fistulizing Crohn's disease 2
Important Considerations
Clinical closure does not equal MRI closure, with high risk of recurrence without complete fibrotic tract on MRI 1
Active luminal disease should be treated concurrently, as perianal fistulas are often associated with active disease elsewhere 1
Long-term monitoring is essential as perianal fistulas in Crohn's disease have high rates of primary non-healing, surgical morbidity, and recurrence 5
Maintenance therapy with immunomodulators should be considered after initial response to prevent recurrence 1
Regular monitoring for development of malignancy in chronic perianal fistula tracts is recommended 1